Relay Therapeutics, Inc. (RLAY) Operating margin 2020–2025
Relay Therapeutics, Inc. (RLAY) operating margin by fiscal year — reported operating income divided by reported revenue.
-1971.6%FY2025 · since FY2020: -67.5% → -1971.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1971.6% | +1750.5 pp |
| FY2024 | -3722.1% | -2262.0 pp |
| FY2023 | -1460.1% | +20210.8 pp |
| FY2022 | -21670.9% | -9630.7 pp |
| FY2021 | -12040.2% | -11972.7 pp |
| FY2020 | -67.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RLAY financial trends
RLAY RevenueRLAY Net incomeRLAY Net marginRLAY Gross profitRLAY Gross marginRLAY Operating incomeRLAY Operating cash flowRLAY Free cash flowRLAY Capital expendituresRLAY Return on equityRLAY Stock buybacksRLAY Dividends paidRLAY Total assetsRLAY Total liabilitiesRLAY Shareholders’ equityRLAY overview →